Home
>
National Drug Code (NDC)
>
Ribasphere
Ribasphere - 66435-101-14 - (Ribavirin)
Drug Information of Ribasphere
| Product NDC: | 66435-101 |
| Proprietary Name: | Ribasphere |
| Non Proprietary Name: | Ribavirin |
| Active Ingredient(s): | 200 mg/1 & nbsp; Ribavirin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ribasphere
| Product NDC: | 66435-101 |
| Labeler Name: | Kadmon Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076203 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040407 |
Package Information of Ribasphere
| Package NDC: | 66435-101-14 |
| Package Description: | 140 CAPSULE in 1 BOTTLE, PLASTIC (66435-101-14) |
NDC Information of Ribasphere
| NDC Code | 66435-101-14 |
| Proprietary Name | Ribasphere |
| Package Description | 140 CAPSULE in 1 BOTTLE, PLASTIC (66435-101-14) |
| Product NDC | 66435-101 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ribavirin |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20040407 |
| Marketing Category Name | ANDA |
| Labeler Name | Kadmon Pharmaceuticals, LLC |
| Substance Name | RIBAVIRIN |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
